Clinical Trials Browser

Phase NA × Nivolumab × Gastrointestinal × Clear all

NCT07053202 2025-07-08

TACE With Immune Agents for Angiogenesis in Hepatocellular Carcinoma

Phase NA Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT05233358 2022-02-10

HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT05001360 2021-10-27

Study of FMT Combined With Nivolumab in Gastric Cancer

Phase NA Withdrawn

Gastrointestinal

Adenocarcinoma Of Esophagus